Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
MD

MEDNAX Inc

MD

9.23USD-0.11 (-1.18%)Market Closed
Watchlist

Market Summary

USD9.23-0.11
Market Closed
-1.18%

MD Stock Price

View Fullscreen

MD RSI Chart

MD Valuation

Market Cap

774.7M

Price/Earnings (Trailing)

8.28

Price/Sales (Trailing)

0.39

EV/EBITDA

7

Price/Free Cashflow

4.65

MD Price/Sales (Trailing)

MD Profitability

EBT Margin

6.58%

Return on Equity

11.18%

Return on Assets

4.38%

Free Cashflow Yield

21.53%

MD Fundamentals

MD Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

3.41%

Revenue Q/Q

1.21%

MD Earnings

Earnings (TTM)

93.5M

Earnings Y/Y

-30.39%

Earnings Q/Q

-24.37%

Price Action

Last 7 days

11.3%

Last 30 days

-5.7%

Last 90 days

-26.7%

Trailing 12 Months

-40.4%

How does MD drawdown profile look like?

MD Financial Health

Current Ratio

1.44

MD Investor Care

Shares Dilution (1Y)

1.11%

Diluted EPS (TTM)

1.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.0B2.0B2.0B0
20221.9B2.0B2.0B2.0B
20211.7B1.8B1.8B1.9B
20201.8B1.8B1.8B1.7B
20193.0B2.6B2.2B1.8B
20183.5B3.5B3.5B3.5B
20173.3B3.3B3.4B3.5B
20162.9B3.0B3.1B3.2B
20152.5B2.6B2.7B2.8B
20142.2B2.3B2.4B2.4B
20131.9B2.0B2.1B2.2B
20121.6B1.7B1.8B1.8B
20111.5B1.5B1.6B1.6B
20101.3B1.3B1.4B1.4B
20091.1B1.2B1.2B1.3B
20080001.1B

Latest Insider Trading transactions for MD

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 14, 2023
swift james d
sold
-186,549
14.14
-13,193
chief executive officer
Jun 07, 2023
pickert curtis
gifted
-
-
-1,166
evp, chief operating officer
Jun 01, 2023
wood lee
sold (taxes)
-5,413
13.3
-407
evp, natl & market operations
Jun 01, 2023
pickert curtis
sold (taxes)
-5,000
13.3
-376
evp, chief operating officer
May 25, 2023
ordan mark s
sold
-437,580
13.26
-33,000
-
May 19, 2023
weis shirley a
sold
-13,725
13.63
-1,007
-
May 18, 2023
weis shirley a
sold
-243,805
13.55
-17,993
-
May 15, 2023
pickert curtis
gifted
-
-
-5,984
evp, chief operating officer
May 12, 2023
young sylvia jean
acquired
-
-
10,831
-
May 11, 2023
weis shirley a
acquired
-
-
10,965
-

1–10 of 50

Which funds bought or sold MD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-41.11
-546,757
608,530
-%
Nov 24, 2023
DEUTSCHE BANK AG\
added
8.97
-13,426
517,246
-%
Nov 22, 2023
KBC Group NV
unchanged
-
-
97,000
-%
Nov 22, 2023
Public Sector Pension Investment Board
reduced
-30.21
-782,628
1,299,890
0.01%
Nov 21, 2023
COMERICA BANK
new
-
616,944
616,944
-%
Nov 17, 2023
JACOBS LEVY EQUITY MANAGEMENT, INC
reduced
-10.1
-560,346
2,299,660
0.01%
Nov 15, 2023
CAPTRUST FINANCIAL ADVISORS
new
-
197,831
197,831
-%
Nov 15, 2023
MANUFACTURERS LIFE INSURANCE COMPANY, THE
added
24.82
56,375
540,353
-%
Nov 15, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
1.91
-4,000
45,000
-%
Nov 15, 2023
JANE STREET GROUP, LLC
sold off
-100
-740,099
-
-%

1–10 of 49

Latest Funds Activity

Are funds buying MD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MD
No. of Funds

Schedule 13G FIlings of MEDNAX Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 10, 2023
alliancebernstein l.p.
10.0%
8,392,304
SC 13G/A
Feb 14, 2023
alliancebernstein l.p.
7.8%
6,468,122
SC 13G/A
Feb 14, 2023
earnest partners llc
7.9%
6,546,580
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
11.72%
9,738,017
SC 13G/A
Jan 23, 2023
blackrock inc.
16.5%
13,672,143
SC 13G/A
Jan 20, 2023
starboard value lp
4.0%
3,348,578
SC 13D/A
Dec 02, 2022
starboard value lp
7.1%
5,915,000
SC 13D/A
Feb 14, 2022
arrowmark colorado holdings llc
3.10%
2,683,879
SC 13G/A
Feb 14, 2022
alliancebernstein l.p.
8.5%
7,359,083
SC 13G/A

Recent SEC filings of MEDNAX Inc

View All Filings
Date Filed Form Type Document
Nov 02, 2023
8-K
Current Report
Nov 02, 2023
10-Q
Quarterly Report

MD Fair Value

Loading...

Peers (Alternatives to MEDNAX Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
508.7B
360.0B
1.94% 1.34%
23.46
1.41
14.24% 11.62%
96.7B
347.8B
5.35% -27.64%
11.1
0.28
10.34% 159.11%
91.1B
189.9B
-12.60% -22.05%
13.64
1.92
5.24% 22.27%
69.2B
63.2B
8.96% 6.67%
12.11
1.1
5.62% 6.32%
39.4B
150.1B
3.44% -15.03%
16.13
0.26
6.04% 21.35%
MID-CAP
9.8B
11.9B
32.01% 41.29%
16.13
0.82
2.36% -10.41%
9.6B
14.0B
3.25% 4.87%
14.25
0.69
6.03% -8.61%
8.6B
2.2B
-1.50% 10.15%
35.34
3.88
4.50% -6.69%
6.7B
2.9B
-3.11% -12.16%
-365.93
2.34
13.16% -106.47%
2.6B
4.1B
9.38% -42.09%
9.25
0.63
-25.26% -41.25%
SMALL-CAP
1.6B
1.3B
13.24% 13.97%
34.86
1.17
27.06% -27.04%
1.5B
1.0B
6.69% -15.76%
25.78
1.44
10.84% 30.19%
1.0B
3.0B
18.37% 74.00%
-8.11
0.34
6.98% 58.07%
35.8M
-
2.22% -73.51%
-2.47
-
- -27.68%
15.8M
20.7M
7.02% -13.27%
54.39
0.76
6.53% -78.75%

MEDNAX Inc News

Latest updates
Nasdaq30 Nov 202308:00 am8 days ago
Business Wire18 May 202307:00 am6 months ago
DLA Piper26 Dec 202204:42 pm11 months ago
Business Wire21 Jun 202207:00 am17 months ago
StreetInsider.com12 Apr 202207:00 am20 months ago
Nasdaq11 Mar 202208:00 am21 months ago
Business Wire17 Feb 202208:00 am21 months ago
Nasdaq07 Feb 202208:00 am22 months ago
Yahoo Finance07 Feb 202208:00 am22 months ago
PR Newswire07 Oct 202107:00 am2 years ago
StreetInsider.com20 Aug 202107:00 am2 years ago
Yahoo Finance16 Jul 202107:00 am2 years ago
Yahoo Finance17 Jun 202107:00 am2 years ago
ThinkMarkets15 Jun 202104:37 pm2 years ago
TMS Brokers13 May 202104:04 pm2 years ago

Financials for MEDNAX Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue1.2%507501491514490486482499493473447417461415441459455439427888849
Operating Expenses3.2%466452461478443436443431434423421384440381430418406396387783745
  S&GA Expenses-1.0%57.0058.0059.0051.0058.0061.0061.0059.0067.0071.0067.0055.0066.0060.0067.0059.0063.0063.0059.0010696.00
EBITDA Margin---0.10*0.08*0.10*0.10*0.10*0.12*0.11*0.10*0.09*0.09*0.09*-0.70*-0.69*-0.53*-----
Interest Expenses-7.6%10.0011.0010.0010.0010.008.0012.0017.0018.0017.0018.0027.0027.0028.0028.0028.0030.0031.0030.0025.0022.00
Income Taxes-11.5%9.0011.007.004.0010.0012.00-7.4013.0012.007.00-4.956.007.003.001.004.007.007.00-1.5122.0024.00
Earnings Before Taxes-20.8%31.0039.0021.0028.0039.0043.00-28.3554.0043.0038.000.0010.004.0010.00-17.4114.0020.0013.0011.0083.0086.00
EBT Margin---0.07*0.04*0.05*0.06*0.05*0.07*0.05*0.03*0.01*0.00*0.01*-0.78*-0.77*-0.59*-----
Net Income-24.4%21.0028.0014.0030.0031.0027.00-21.1948.0031.0035.0018.00-64.30-41.04-672-18.719.00-1,255-8.24-24260.0066.00
Net Income Margin---0.05*0.03*0.04*0.04*0.05*0.07*0.01*-0.03*-0.44*-0.46*-0.41*-1.09*-0.71*-0.68*-----
Free Cashflow----10099.0083.0082.00-97.4844.0061.0054.00-82.19-11.87170188-141135-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets0.9%2,3262,3062,3202,3482,3322,3702,3412,7232,6462,5552,4843,3483,4253,3874,3204,1464,2915,6395,7065,9375,839
  Current Assets5.7%4213984094284244594408417887526651,5491,6516889417329659861,057660625
    Cash Equivalents262.1%21.006.006.0010.009.0014.007.003873583382701,12429513231210825.0036.0046.0041.0042.00
  Net PPE2.5%75.0073.0073.0073.0072.0072.0072.0070.0073.0068.0081.0076.0079.0098.0010073.0094.0093.0089.0090.00138
  Goodwill0%1,5321,5321,5321,5321,5321,5321,5291,5101,4971,4871,4821,4801,4812,1652,7101,4802,6354,0704,0664,0614,303
Liabilities-0.4%1,3581,3631,4101,4561,4731,5241,4641,8261,8001,7461,7172,6002,6202,5612,8322,6472,8112,9142,9262,8502,823
  Current Liabilities9.4%350320284427352329270427398351327444488384346542501441415503436
  Long Term Debt-0.6%622625-632-----------------
Shareholder's Equity2.7%9689429108928598458778978468097677488058271,4871,4991,4792,7252,7803,0883,015
  Retained Earnings45.9%-25.18-46.57-74.86-89.06-118-149-176-155-202-233-268-286-222-1794915105011,7571,8012,0942,016
  Additional Paid-In Capital0.4%9969929879849819971,0541,0501,0451,0391,0321,0291,0241,005995988978967978993999
Shares Outstanding0.1%84.0084.0084.0083.0083.0085.0085.0086.0085.0085.0085.0086.0084.0083.0083.0084.0082.0083.0086.0088.0091.00
Minority Interest--------0.000.000.000.000.000.00--------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-10.2%79,93889,054-100,91798,68683,33082,407-97,48244,23661,10253,587-82,188-11,866169,935188,435-141,884135,297159,199120,032-56,817151,377140,727
  Share Based Compensation1.2%3,1643,1263,0093,2364,1204,3364,4354,0215,4955,7353,7172,92222,9465,7317,4435,8986,6599,86410,9897,8358,742
Cashflow From Investing-34.7%-14,004-10,398-11,350-11,241-6,088-13,352-26,273-15,584-41,21414,089-10,364840,611-3,441-1,439-20,220156,977-26,888-18,943-8,691-94,989-8,806
Cashflow From Financing35.9%-50,604-78,931108,567-86,289-82,662-62,146-256,457825-131851-761,661586-4,133-366,650366,039-209,499-143,150-107,08566,664-30,321-135,515
  Buy Backs1109.1%13311.007751,48021,47764,3981,166-2,4742511,994-2.005,4525012,54235641565,52778,982-250,000

MD Income Statement

2023-09-30
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net revenue$ 506,612$ 489,915$ 1,498,197$ 1,458,177
Operating expenses:    
Practice salaries and benefits368,404342,8501,084,6711,016,762
Practice supplies and other operating expenses31,31931,85793,12890,189
General and administrative expenses57,40657,888174,478180,340
Depreciation and amortization9,2118,95627,10926,500
Transformational and restructuring related expenses097707,736
Total operating expenses466,340442,5281,379,3861,321,527
Income from operations40,27247,387118,811136,650
Investment and other income2736172,0962,336
Interest expense(10,374)(9,516)(31,994)(29,743)
Loss on early extinguishment of debt000(57,016)
Equity in earnings of unconsolidated affiliate6613711,5781,319
Total non-operating expenses(9,440)(8,528)(28,320)(83,104)
Income from continuing operations before income taxes30,83238,85990,49153,546
Income tax provision(9,441)(10,051)(26,612)(14,982)
Income from continuing operations21,39128,80863,87938,564
Income (loss) from discontinued operations, net of tax01,9200(1,892)
Net income21,39130,72863,87936,672
Net loss attributable to noncontrolling interest0004
Net income attributable to Pediatrix Medical Group, Inc.21,39130,72863,87936,676
Other comprehensive (loss) income, net of tax1(1,515)218(5,417)
Total comprehensive income attributable to Pediatrix Medical Group, Inc.$ 21,392$ 29,213$ 64,097$ 31,259
Net income attributable to Pediatrix Medical Group, Inc.:    
Basic$ 0.26$ 0.37$ 0.78$ 0.44
Diluted$ 0.26$ 0.37$ 0.77$ 0.43
Weighted average common shares:    
Basic82,54382,12682,12784,122
Diluted82,95082,77682,49284,821

MD Balance Sheet

2023-09-30
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 21,179$ 9,824
Short-term investments103,54193,239
Accounts receivable, net277,352296,787
Prepaid expenses10,58614,878
Other current assets7,86613,261
Total current assets420,524427,989
Property and equipment, net75,14673,290
Goodwill1,532,0921,532,092
Intangible assets, net15,48618,491
Operating and finance lease right-of-use assets72,44366,924
Deferred income tax assets102,638105,925
Other assets108,010123,176
Total assets2,326,3392,347,887
Current liabilities:  
Accounts payable and accrued expenses302,583374,225
Current portion of debt and finance lease liabilities, net14,92914,898
Current portion of operating lease liabilities21,81421,589
Income taxes payable11,11816,271
Total current liabilities350,444426,983
Line of credit04,000
Long-term debt and finance lease liabilities, net621,691632,381
Long-term operating lease liabilities48,48944,213
Long-term professional liabilities265,523275,629
Deferred income tax liabilities41,01833,638
Other liabilities31,18939,411
Total liabilities1,358,3541,456,255
Commitments and contingencies
Shareholders' equity:  
Preferred stock; $.01 par value; 1,000 shares authorized; none issued00
Common stock; $.01 par value; 200,000 shares authorized; 83,929 and 82,947 shares issued and outstanding, respectively839829
Additional paid-in capital995,847983,601
Accumulated other comprehensive loss(3,517)(3,735)
Retained deficit(25,184)(89,063)
Total shareholders' equity967,985891,632
Total liabilities and shareholders' equity$ 2,326,339$ 2,347,887
MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
 CEO
 WEBSITEwww.pediatrix.com
 EMPLOYEES5250

MEDNAX Inc Frequently Asked Questions


What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MEDNAX Inc (MD)?

As of Thu Dec 07 2023, market cap of MEDNAX Inc is 783.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MD stock?

You can check MD's fair value in chart. The fair value of MEDNAX Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MEDNAX Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MEDNAX Inc a good stock to buy?

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, MD's PE ratio (Price to Earnings) is 8.37 and Price to Sales (PS) ratio is 0.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MEDNAX Inc's stock?

In the past 10 years, MEDNAX Inc has provided -0.164 (multiply by 100 for percentage) rate of return.